|
gptkbp:instanceOf
|
gptkb:drug
anticholinergic drug
|
|
gptkbp:ATCCode
|
N04AC01
|
|
gptkbp:CASNumber
|
86-13-5
|
|
gptkbp:chemicalFormula
|
C21H25NO
|
|
gptkbp:contraindication
|
gptkb:myasthenia_gravis
narrow-angle glaucoma
|
|
gptkbp:discoveredBy
|
gptkb:Merck_&_Co.
|
|
gptkbp:eliminationHalfLife
|
12-24 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
benztropine
|
|
gptkbp:introducedIn
|
1954
|
|
gptkbp:KEGGID
|
gptkb:D00208
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
muscarinic acetylcholine receptor antagonist
antihistaminic activity
|
|
gptkbp:MedlinePlusID
|
a682187
|
|
gptkbp:molecularWeight
|
307.43 g/mol
|
|
gptkbp:partOf
|
gptkb:World_Health_Organization's_List_of_Essential_Medicines
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:proteinBinding
|
95%
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1201292
2381
DB00245
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
intravenous
|
|
gptkbp:sideEffect
|
confusion
constipation
blurred vision
tachycardia
dry mouth
urinary retention
|
|
gptkbp:synonym
|
gptkb:Cogentin
gptkb:benztropine_mesylate
|
|
gptkbp:UNII
|
6LR8C1B66Q
|
|
gptkbp:usedFor
|
gptkb:Parkinson's_disease
extrapyramidal symptoms
|
|
gptkbp:bfsParent
|
gptkb:dopamine_transporter
|
|
gptkbp:bfsLayer
|
7
|